2025 Health Tech Competition - Best Science Pitch Winner
Winner of the Best Science Pitch in the 2025 Health Tech Competition, Brainomix. From left to right: Star Jones, lawyer/TV personality and American Heart Association national volunteer; Dr. Davide Carone, senior medical director of Brainomix; Dr. Michael Papadakis, chief executive officer and co-founder of Brainomix; and Nancy Brown, chief executive officer of the American Heart Association.
Overall winner and winner of the Best Business Pitch in the 2025 Health Tech Competition, PolyVascular. From left to right: Star Jones, lawyer/TV personality and American Heart Association national volunteer; Dr. Henri Justino, co-founder of PolyVascular; and Nancy Brown, chief executive officer of the American Heart Association.
consultant cardiologist at Cardiovascular Department, University of Trieste, Italy; researcher at the National Amyloidosis Centre, University College London
Alta Schutte, Ph.D., a professor of cardiovascular medicine at the University of New South Wales Sydney and The George Institute for Global Health in Australia
copyright University of New South Wales Sydney and The George Institute photographers
Ambarish Pandey, M.D., M.S., FAHA, an associate professor of internal medicine in the division of cardiology and geriatrics at UT Southwestern Medical Center in Dallas and medical director of the center’s heart failure with preserved ejection fraction program.
Presents finding on FOOD-HF – Examining the Impact of Medically Tailored Meals vs Produce Supplements Delivered Conditionally vs Unconditionally on Heart Failure Readmissions and Emergency Department Visits: A Randomized Clinical Trial (LBS.07) and POLY-HF – A Polypill Strategy for Heart Failure with Reduced Ejection Fraction: The POLY-HF Trial (LBS.07)
Ambarish Pandey, M.D., M.S., FAHA, an associate professor of internal medicine in the division of cardiology and geriatrics at UT Southwestern Medical Center in Dallas and medical director of the center’s heart failure with preserved ejection fraction program
American Heart Association volunteer expert, Amit Khera, M.D., FAHA, is director of preventive cardiology and clinical chief of cardiology at the University of Texas (UT) Southwestern Medical Center, offers perspective during the Scientific Sessions 2025 embargoed media briefing ! in New Orleans.
Amish Deshmukh, M.D., lead author of the study and clinical assistant professor of medicine at the University of Michigan in Ann Arbor. Presents findings on META-AF – Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation (META- AF) (LBS.04)
Moderator: Andrea M. Russo, M.D., FAHA, professor of medicine at Cooper Medical School of Rowan University, director of electrophysiology and arrhythmia services, director of research at the Cooper Heart Institute and program director of Clinical Cardiology Electrophysiology Fellowship at Cooper University Health Care in Voorhees Township, New Jersey.
Ann Marie Navar, M.D., Ph.D., FAHA, an associate professor of cardiology at the University of Texas Southwestern Medical Center in Dallas. Presents findings in CORALreef Lipids – Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial (PL.ME.02).
Arya Aminorroaya, M.D., MPH, an internal medicine resident at Yale New Haven Hospital and a research affiliate at the Cardiovascular Data Science (CarDS) Lab at Yale School of Medicine in New Haven, Connecticut
Attendees enjoy puppy time at the American Heart Association's 2025 Scientific Sessions, Monday, November 10, 2025, at the New Orleans Ernest N. Morial Convention Center.
copyright American Heart Association, photographer Luke Franke 2025
Atul Verma, M.D., director of cardiology at McGill University Health Centre in Montreal, Canada. Presents findings on OCEAN, The Need for Ongoing Oral Anticoagulation in Patients with Clinical Stroke Risk Factors After Successful Catheter Ablation of Atrial Fibrillation: The OCEAN Randomized Trial (LBS.02)
Attendees during the President's Session at the American Heart Association's 2025 Scientific Sessions, Sunday, November 9, 2025, at the Ernest N. Morial Convention Center.
copyright American Heart Association, photographer Phil McCarten 2025
Moderator: Brahmajee Nallamothu, M.D., M.P.H., FAHA, vice chair of the American Heart Association’s Committee on Scientific Sessions Programming, director of the Michigan Integrated Center for Health Analytics and Medical Prediction and professor in the division of cardiovascular diseases and the department of internal medicine at the University of Michigan in Ann Arbor
Christopher X. Wong, M.B.B.S., M.Sc., M.P.H., Ph.D.
Christopher X. Wong, M.B.B.S., M.Sc., M.P.H., Ph.D., formerly of the University of California, San Francisco, and currently professor of cardiology at the University of Adelaide in Australia
Colin Berry, M.B.Ch.B., Ph.D., professor of cardiology at the University of Glasgow and consultant at Golden Jubilee University National Hospital
Presents findings on CorCMR - Non-Invasive Endotyping in Patients with Angina and No Obstructive Coronary Artery Disease: A Randomized, Controlled Trial (LBS.06)
Moderator: Daniel W. Jones, M.D., FAHA, chair of the writing committee for the 2025 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM /AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults, past volunteer president of the American Heart Association, and dean and professor emeritus of the University of Mississippi School of Medicine in Jackson, Mississippi
Expert Donna K. Arnett, Ph.D., FAHA, past volunteer president of the American Heart Association, tenured professor at the University of South Carolina’s Arnold School of Public Health
Erin Bohula, M.D., D.Phil., Assistant Professor, Harvard Medical School, Associate Physician, Brigham and Women’s Hospital Investigator, TIMI Study Group, Boston, presents findings in Effect of Evolocumab in the abstract "Patients at High Cardiovascular Risk without Prior Myocardial Infarction or Stroke: Primary Results of the VESALIUS-CV trial (LBS 1) at the embargoed media briefing at Scientific Sessions 2025.
Erin Bohula, M.D., D.Phil., Assistant Professor, Harvard Medical School, Associate Physician, Brigham and Women’s Hospital Investigator, TIMI Study Group, Boston
American Heart Association's 2025 Scientific Sessions, Thursday, November 6, 2025, at the McCormick Convention Center. Scientific Sessions is the leading cardiovascular meeting for basic, translational, clinical and population science, in the United States, with cardiovascular experts from around the world attending the meeting.
copyright American Heart Association, photographer Todd Buchanan 2025
Heidi T. May, Ph.D., M.S.P.H., FAHA, principal investigator of TARGET-D and an epidemiologist and professor of research at Intermountain Health in Salt Lake City, Utah.
Jianping Li, M.D., Ph.D., professor and executive deputy director in the department of cardiology at Peking University First Hospital in China, presents findings on DR10624, a First-In-Class, FGF21 Receptor/Glucagon Receptor/GLP-1 Receptor Triple Agonist, Rapidly and Significantly Reduced Triglycerides, Atherogenic Lipids, and Liver Fat in Patients With Severe Hypertriglyceridemia: Primary Results From a Randomized Phase 2 Trial (LBS.01) at the embargoed media briefing at Scientific Sessions 2025.
Joanna Chikwe, M.D., FAHA, Chair of the Association’s 2025 Council on Scientific Sessions Programming, the Irina and George Schaeffer Distinguished Professor & Chair of the Department of Cardiac Surgery at Cedars-Sinai Smidt Heart Institute in Los Angeles, moderates the Scientific Sessions 2025 embargoed media briefing ! in New Orleans.
John Dodson, M.D., principal investigator of the study and associate professor of medicine and population health at the NYU Grossman School of Medicine in New York
Presents findings on BETTER BP – Primary results of the Behavioral Economics Trial to Enhance Regulation of Blood Pressure (LBS.05)
John Dodson, M.D., principal investigator of the study and associate professor of medicine and population health at the NYU Grossman School of Medicine in New York
AmericanHeart Association volunteer expert, Kiran Musunuru, M.D., Ph.D., M.P.H., M.L., FAHA, professor of medicine and director of the Genetic and Epigenetic Origins of Disease Program at Penn Cardiovascular Institute at the Perelman School of Medicine, University of Pennsylvania, and scientific director of the Penn Center for Inherited Cardiovascular Disease at the Hospital of the University of Pennsylvania offers perspective during the Scientific Sessions 2025 embargoed media briefing ! in New Orleans.
Kosuke Kawai, Sc.D., adjunct associate professor in the division of general internal medicine and health services research at the David Geffen School of Medicine at the University of California, Los Angeles
Luc Djoussé, M.D., a research health scientist (cardiovascular epidemiologist) at Massachusetts Veterans Epidemiology Research and Information Collaborative (MAVERIC), Boston VA and an associate professor of medicine at Harvard Medical School, both in Boston. Presents VALOR-QI - A Novel Approach to Manage Hypercholesterolemia: The Veterans Affairs Lipid Optimization Reimagined Quality Improvement (VALOR-QI) Program (FS-11).
Luc Djoussé, M.D., a research health scientist (cardiovascular epidemiologist) at Massachusetts Veterans Epidemiology Research and Information Collaborative (MAVERIC), Boston VA and an associate professor of medicine at Harvard Medical School, both in Boston
Luke J. Laffin, M.D., preventive cardiologist at the Cleveland Clinic presents findings of the First-in-Human Phase 1 Clinical Trial of a CRISPR-Cas9 Gene Editing Therapy Targeting ANGPTL3 (LBS.01) at the embargoed media briefing at Scientific Sessions 2025.
Manesh R. Patel, M.D., FAHA, Volunteer President-elect of the American Heart Association 2025-2026 and chief of the division of cardiology, chief of the division of pharmacology and co-director of the Duke Heart Center in Durham, North Carolina.
Mohammad Abdel Jawad, M.D., M.S., a research fellow of the University of Missouri-Kansas City and Saint Luke’s Mid America Heart Institute in Kansas City, Missouri
American Heart Association CEO, Nancy Brown during the President's Session - Awardees and at the American Heart Association's 2025 Scientific Sessions, Sunday, November 9, 2025, at the Ernest N. Morial Convention Center.
copyright American Heart Association, photographer Phil McCarten 2025
Attendees at the American Heart Association's 2025 Scientific Sessions, Saturday, November 8, 2025, at the New Orleans Ernest N. Morial Convention Center. copyright American Heart Association, photographer Scott Morgan 2025
Panos Kougias, M.D., M.Sc.
SUNY Downstate Health Sciences University, Brooklyn, presents findings on TOP, Liberal or Restrictive Transfusion Strategy after General and Vascular Surgery: The Transfusion Trigger after Major Operations in High Cardiac Risk Patients Trial (LBS.03)
Paul J. Wang, M.D., FAHA, director of the Stanford Cardiac Arrhythmia Service and a professor of medicine and bioengineering at Stanford University, and editor-in-chief of the American Heart Association’s journal Circulation: Arrhythmia and Electrophysiolog.
Peter Tontonoz, M.D., Ph.D., the Frances and Albert Piansky Endowed Chair and distinguished professor of pathology and laboratory medicine and of biological chemistry at the University of California, Los Angeles (UCLA), David Geffen School of Medicine and UCLA Health
Jun Cai, M.D., Ph.D., hospital director at Beijing Anzhen Hospital, Capital Medical University in China
Presents findings on Healthy Family – A multifaceted family intervention for blood pressure management in rural China: an open label, parallel group, cluster randomized trial (LBS.05)
Ulf Landmesser, M.D., professor of cardiology, angiology and intensive care medicine at Charite University Medicine in Berlin, Germany. Presents findings on CLOSURE-AF, Left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding compared to medical therapy (LBS.02)
Moderator: Rasha Al-Lamee, M.D., Ph.D., clinical professor of cardiology at Imperial College London and clinical academic interventional cardiology consultant at Imperial College NHS Trust in London
Richard Kazibwe, M.D., M.S., lead researcher and an assistant professor of internal medicine at Wake Forest University School of Medicine in Winston-Salem, North Carolina
copyright Wake Forest University School of Medicine
Shady Abohashem, M.D., M.P.H., head of cardiac PET/CT imaging trials at Massachusetts General Hospital and an instructor at Harvard Medical School in Boston
ShopHeart booth at the American Heart Association's 2025 Scientific Sessions, Sunday, November 9, 2025, at the McCormick Convention Center. Scientific Sessions is the leading cardiovascular meeting for basic, translational, clinical and population science, in the United States, with cardiovascular experts from around the world attending the meeting.
copyright American Heart Association, photographer Todd Buchanan 2025
Sripal Bangalore, M.D., M.H.A., FAHA, a professor of medicine at NYU Grossman School of Medicine in New York City
Presents findings on TUXEDO-2 - Ticagrelor versus Prasugrel in Patients with Diabetes Mellitus and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Randomized Comparison from the TUXEDO-2 Trial (LBS.06)
Attendees at the American Heart Association's 2025 Scientific Sessions, Saturday, November 8, 2025, at the New Orleans Ernest N. Morial Convention Center. copyright American Heart Association, photographer Scott Morgan 2025
American Heart Association 2025-2026 volunteer President Stacey E. Rosen, M.D., FAHA, executive director for Northwell’s Katz Institute for Women’s Health, senior vice president of Women’s Health at Northwell, the Partners Council Professor of Women’s Health and professor of cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York City offers opening remarks at the Scientific Sessions 2025 embargoed media briefing in New Orleans.
Stacey E. Rosen delivers SS25 presidential address
American Heart Association 2025-2026 volunteer President Stacey E. Rosen, M.D., FAHA, executive director for Northwell’s Katz Institute for Women’s Health, senior vice president of Women’s Health at Northwell, the Partners Council Professor of Women’s Health and professor of cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York City delivers her presidential Address at the Scientific Sessions 2025 in New Orleans.
Stacey E. Rosen delivers SS25 presidential address wide shot
American Heart Association 2025-2026 volunteer President Stacey E. Rosen, M.D., FAHA, executive director for Northwell’s Katz Institute for Women’s Health, senior vice president of Women’s Health at Northwell, the Partners Council Professor of Women’s Health and professor of cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York City delivers her presidential Address at the Scientific Sessions 2025 in New Orleans.
American Heart Association 2025-2026 volunteer President Stacey E. Rosen, M.D., FAHA, executive director for Northwell’s Katz Institute for Women’s Health, senior vice president of Women’s Health at Northwell, the Partners Council Professor of Women’s Health and professor of cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York City delivers her presidential Address at the Scientific Sessions 2025 in New Orleans.
Stephen P. Juraschek, M.D., Ph.D., FAHA, a physician investigator at Beth Israel Deaconess Medical Center, an associate professor of medicine at Harvard Medical School and an associate professor of nutrition at Harvard T.H. Chan School of Public Health, all in Boston
Presents findings on DASH/Go Fresh – DASH-Patterned Groceries Reduce Blood Pressure: Results from the GoFresh Randomized Clinical Trial (LBS.05)
Stephen P. Juraschek, M.D., Ph.D., FAHA, a physician investigator at Beth Israel Deaconess Medical Center, an associate professor of medicine at Harvard Medical School and an associate professor of nutrition at Harvard T.H. Chan School of Public Health, all in Boston
copyright Timothy Plante at UVM College of Medicine
William F. Fearon, M.D., FAHA, professor of medicine and chief of interventional cardiology at Stanford University School of Medicine in Stanford, California
Presents findings on CAVIAR – Cardiac Allograft Vasculopathy Inhibition with AliRocumab: The CAVIAR Trial (LBS.07)
William F. Fearon, M.D., FAHA, professor of medicine and chief of interventional cardiology at Stanford University School of Medicine in Stanford, California
Xuan-Mai Nguyen, M.D., Ph.D., Department of Veterans Affairs Boston Healthcare System researcher and second-year STAR-PSTP resident physician at the University of California, Los Angeles
Yilin Yoshida, Ph.D., M.P.H, FAHA, an assistant professor of medicine and head of the Yilin Yoshida Lab which studies precision diabetes management at Tulane University School of Medicine in New Orleans
Yohei Sotomi, M.D., Ph.D., director of the Osaka Cardiovascular Conference Multicenter Clinical Research Lab in the department of cardiovascular medicine at University of Osaka Graduate School of Medicine in Osaka, Japan. Presents findings on OPTIMA-AF, Short Dual Antithrombotic Therapy after PCI in Patients with Atrial Fibrillation: OPTIMA-AF trial (LBS.02)
Yohei Sotomi, M.D., Ph.D., director of the Osaka Cardiovascular Conference Multicenter Clinical Research Lab in the department of cardiovascular medicine at University of Osaka Graduate School of Medicine in Osaka, Japan.
copyright University of Osaka Graduate School of Medicine
